Clinical-parameter XGBoost model stratified patients into low-risk and high-risk groups with 94.0% vs 65.0% 2-year local control after carbon-ion radiotherapy for early-stage peripheral NSCLC.
Source article: Local Recurrence Prediction After Carbon-ion Radiotherapy for Early-stage Non-small Cell Lung Cancer Using Machine Learning
Anticancer ResearchHow should this claim be treated?
ace